Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/13336
Title: The cardiac renin-angiotensin system in heart failure.
Authors: Johnston, Colin I;Fabris, Bruno;Yoshida, K
Affiliation: Department of Medicine, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia.
Issue Date: 1-Sep-1993
Citation: American Heart Journal; 126(3 Pt 2): 756-60
Abstract: The success of angiotensin-converting enzyme (ACE) inhibitors in reducing cardiovascular morbidity and mortality rates has led to a reexamination of the role of the renin-angiotensin system in pathophysiology. Ventricular dysfunction leading to congestive cardiac failure is associated with sequential activation of the sympathetic system and increases in plasma atrial natriuretic peptide; however, increases in plasma renin and aldosterone do not occur until very late. The renin-angiotensin system is now regarded as both a circulating and tissue hormonal system. All components of the renin-angiotensin system have been detected in the heart. ACE is localized in discrete areas of the heart, including the cardiac valves, coronary vessels, atria, and myocardium. After experimental myocardial infarction in the rat, although plasma renin and aldosterone levels are not increased, ACE in the myocardium is markedly increased. Treatment with ACE inhibitors suppresses cardiac ACE and is associated with hemodynamic improvement, reversal of the neurohumoral activation, prevention of ventricular dilatation, and remodeling and reduction in mortality rates. These results suggest that the beneficial effects of ACE inhibitors in treating congestive cardiac failure, preventing ventricular remodeling, and regressing left ventricular hypertrophy may involve not only reducing preload and afterload but also suppressing the local cardiac renin-angiotensin system.
Internal ID Number: 8362749
URI: http://ahro.austin.org.au/austinjspui/handle/1/13336
URL: http://www.ncbi.nlm.nih.gov/pubmed/8362749
Type: Journal Article
Subjects: Angiotensin II.blood
Angiotensin-Converting Enzyme Inhibitors.therapeutic use
Animals
Heart Failure.drug therapy.physiopathology
Humans
Myocardium.metabolism
Renin-Angiotensin System.drug effects.physiology
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.